Abstract:Objective: Starch metabolizing enzyme inhibitors are able to retard postprandial glucose absorption. This study aimed to investigate the in vitro inhibitory activities of alpha-glucosidase and alpha-amylase of three Malvaceous weeds i.e. Sidaacuta Burm. f., Abutilon indicum (Linn.) Sweet and Malvastrumcoromandelianum (Linn.) Garcke.
Methods: The stems, roots and leaves of S. acuta, A. indicum and M. coromandelianum were sequentially extracted in dichloromethane and methanol, respectively. All fractions w… Show more
Diabetes Mellitus (DM) is one of the most prevalent chronic conditions bearing considerable social, health, and economic ramifications. Uncontrolled DM manifests secondary complications such as foot ulceration, retinopathy, neuropathy, nephropathy, and cardiomyopathy. The heterogeneity inherent in DM necessitates a comprehensive therapeutic strategy that is equally safe and effective against multifaceted diseases like DM. Conventionally, DM management relies on lifestyle modifications and dietary adjustments, complemented by pharmacological interventions. However, the limitations associated with oral hypoglycaemic agents prompt an exploration of alternative modalities. These days, substantial resources within healthcare are dedicated to investigating traditional systems of medicine, notably Ayurveda and traditional Chinese medicine, seeking novel interventions for DM management. This systematic review aims to evaluate the available literature of 2017-2023, focusing on identifying herbs with potential efficacy in DM management with their potent mechanism of action. By synthesizing current scientific knowledge, the review elucidates the intricate molecular-level mechanisms of action of medicinal plants in DM. This contribution enriches the scientific discourse by providing a comprehensive resource for the nuanced exploration of innovative approaches to address the complex facets of DM. As healthcare endeavours to diversify its strategies, the insights from this review may pave the way for developing novel and effective interventions for managing DM using medicinal plants.
Diabetes Mellitus (DM) is one of the most prevalent chronic conditions bearing considerable social, health, and economic ramifications. Uncontrolled DM manifests secondary complications such as foot ulceration, retinopathy, neuropathy, nephropathy, and cardiomyopathy. The heterogeneity inherent in DM necessitates a comprehensive therapeutic strategy that is equally safe and effective against multifaceted diseases like DM. Conventionally, DM management relies on lifestyle modifications and dietary adjustments, complemented by pharmacological interventions. However, the limitations associated with oral hypoglycaemic agents prompt an exploration of alternative modalities. These days, substantial resources within healthcare are dedicated to investigating traditional systems of medicine, notably Ayurveda and traditional Chinese medicine, seeking novel interventions for DM management. This systematic review aims to evaluate the available literature of 2017-2023, focusing on identifying herbs with potential efficacy in DM management with their potent mechanism of action. By synthesizing current scientific knowledge, the review elucidates the intricate molecular-level mechanisms of action of medicinal plants in DM. This contribution enriches the scientific discourse by providing a comprehensive resource for the nuanced exploration of innovative approaches to address the complex facets of DM. As healthcare endeavours to diversify its strategies, the insights from this review may pave the way for developing novel and effective interventions for managing DM using medicinal plants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.